Biofrontera Inc. Common Stock (BFRI) is a publicly traded Healthcare sector company. As of July 27, 2026, BFRI trades at $1.07 with a market cap of $13.96M and a P/E ratio of -1.05. BFRI moved +0.00% today. Year to date, BFRI is +51.39%; over the trailing twelve months it is -1.36%. Its 52-week range spans $0.54 to $1.87. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces BFRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover BFRI: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $6.00.
| Metric | Value |
|---|---|
| Price | $1.07 |
| Market Cap | $13.96M |
| P/E Ratio | -1.05 |
| EPS | $-1.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.87 |
| 52-Week Low | $0.54 |
| Volume | 47.23K |
| Avg Volume | 0 |
| Revenue (TTM) | $41.70M |
| Net Income | $-10.54M |
| Gross Margin | 0.00% |
2 analysts cover BFRI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.